![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:733012 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SACM1L mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:735467 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SACM1L mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:735467 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of SACM1L mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:735467 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SACM1L mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SACM1L mRNA | CTD | PMID:18796159, PMID:21215274 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:735467 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SACM1L mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:733012 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SACM1L mRNA | CTD | PMID:28628672 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SACM1L mRNA | CTD | PMID:16483693 | antimycin A | decreases expression | ISO | RGD:733012 | 6480464 | Antimycin A results in decreased expression of SACM1L mRNA | CTD | PMID:33512557 | aristolochic acid A | decreases expression | ISO | RGD:733012 | 6480464 | aristolochic acid I results in decreased expression of SACM1L mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:733012 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SACM1L mRNA] | CTD | PMID:32406909 | benzo[e]pyrene | increases methylation | ISO | RGD:733012 | 6480464 | benzo(e)pyrene results in increased methylation of SACM1L promoter | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SACM1L mRNA | CTD | PMID:25181051, PMID:33296240 | Bisphenol B | increases expression | ISO | RGD:733012 | 6480464 | bisphenol B results in increased expression of SACM1L protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | ISO | RGD:733012 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SACM1L mRNA | CTD | PMID:28628672 | bisphenol F | increases expression | ISO | RGD:733012 | 6480464 | bisphenol F results in increased expression of SACM1L protein | CTD | PMID:34186270 | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of SACM1L protein | CTD | PMID:28903499 | chlorpyrifos | decreases expression | ISO | RGD:735467 | 6480464 | Chlorpyrifos results in decreased expression of SACM1L mRNA | CTD | PMID:37019170 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of SACM1L protein | CTD | PMID:34058248 | copper(II) sulfate | decreases expression | ISO | RGD:733012 | 6480464 | Copper Sulfate results in decreased expression of SACM1L mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | RGD:735467 | 6480464 | Asbestos, Crocidolite results in decreased expression of SACM1L mRNA | CTD | PMID:29279043 | dexamethasone | multiple interactions | ISO | RGD:733012 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SACM1L mRNA | CTD | PMID:28628672 | diazinon | increases methylation | ISO | RGD:733012 | 6480464 | Diazinon results in increased methylation of SACM1L gene | CTD | PMID:22964155 | dicrotophos | decreases expression | ISO | RGD:733012 | 6480464 | dicrotophos results in decreased expression of SACM1L mRNA | CTD | PMID:28302478 | ethyl methanesulfonate | decreases expression | ISO | RGD:733012 | 6480464 | Ethyl Methanesulfonate results in decreased expression of SACM1L mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | RGD:735467 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SACM1L mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | RGD:735467 | 6480464 | Folic Acid results in decreased expression of SACM1L mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | RGD:733012 | 6480464 | Formaldehyde results in decreased expression of SACM1L mRNA | CTD | PMID:23649840 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SACM1L mRNA | CTD | PMID:22061828, PMID:33387578 | indometacin | multiple interactions | ISO | RGD:733012 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SACM1L mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:733012 | 6480464 | Ivermectin results in decreased expression of SACM1L protein | CTD | PMID:32959892 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of SACM1L mRNA | CTD | PMID:30467583 | methapyrilene | increases methylation | ISO | RGD:733012 | 6480464 | Methapyrilene results in increased methylation of SACM1L promoter | CTD | PMID:30157460 | methyl methanesulfonate | decreases expression | ISO | RGD:733012 | 6480464 | Methyl Methanesulfonate results in decreased expression of SACM1L mRNA | CTD | PMID:23649840 | N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:735467 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SACM1L protein | CTD | PMID:26558463 | nickel sulfate | decreases expression | ISO | RGD:733012 | 6480464 | nickel sulfate results in decreased expression of SACM1L mRNA | CTD | PMID:16780908 | paracetamol | increases expression | ISO | RGD:735467 | 6480464 | Acetaminophen results in increased expression of SACM1L mRNA | CTD | PMID:17585979 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SACM1L mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:735467 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SACM1L mRNA | CTD | PMID:36331819 | pirinixic acid | increases expression | ISO | RGD:735467 | 6480464 | pirinixic acid results in increased expression of SACM1L mRNA | CTD | PMID:18301758 | potassium chromate | decreases expression | ISO | RGD:733012 | 6480464 | potassium chromate(VI) results in decreased expression of SACM1L mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:733012 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SACM1L mRNA | CTD | PMID:22079256 | resveratrol | multiple interactions | ISO | RGD:733012 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SACM1L mRNA | CTD | PMID:23557933 | rotenone | increases expression | ISO | RGD:733012 | 6480464 | Rotenone results in increased expression of SACM1L mRNA | CTD | PMID:33512557 | sodium arsenate | increases expression | ISO | RGD:735467 | 6480464 | sodium arsenate results in increased expression of SACM1L mRNA | CTD | PMID:21795629 | sodium fluoride | decreases expression | ISO | RGD:735467 | 6480464 | Sodium Fluoride results in decreased expression of SACM1L protein | CTD | PMID:28918527 | succimer | multiple interactions | ISO | RGD:735467 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACM1L mRNA | CTD | PMID:21641980 | tetrachloromethane | decreases expression | ISO | RGD:735467 | 6480464 | Carbon Tetrachloride results in decreased expression of SACM1L mRNA | CTD | PMID:31919559 | tetracycline | increases expression | ISO | RGD:735467 | 6480464 | Tetracycline results in increased expression of SACM1L mRNA | CTD | PMID:16917069 | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of SACM1L protein | CTD | PMID:35544339 | trichloroethene | decreases expression | ISO | RGD:735467 | 6480464 | Trichloroethylene results in decreased expression of SACM1L mRNA | CTD | PMID:19448997 | valproic acid | decreases methylation | ISO | RGD:733012 | 6480464 | Valproic Acid results in decreased methylation of SACM1L gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:733012 | 6480464 | Valproic Acid affects the expression of SACM1L mRNA | CTD | PMID:25979313 | |